Your browser doesn't support javascript.
loading
Logro de metas de prevención secundaria, prescripción farmacológica y eventos cardiovasculares mayores en pacientes con enfermedad coronaria / Achievement of cardiovascular prevention goals, pharmacologic prescription and major cardiovascular events among patients with coronary disease
Neira V, Víctor; Potthoff N, Marcelo; Quiñiñir S, Luis; López R, Gabriel; Stockins F, Benjamín; Castillo B, Carlos; Lanas Z, Fernando.
Affiliation
  • Neira V, Víctor; Universidad de La Frontera. Temuco. CL
  • Potthoff N, Marcelo; Universidad de La Frontera. Temuco. CL
  • Quiñiñir S, Luis; Universidad de La Frontera. Temuco. CL
  • López R, Gabriel; Universidad de La Frontera. Temuco. CL
  • Stockins F, Benjamín; Universidad de La Frontera. Temuco. CL
  • Castillo B, Carlos; Universidad de La Frontera. Temuco. CL
  • Lanas Z, Fernando; Universidad de La Frontera. Temuco. CL
Rev. méd. Chile ; 141(7): 870-878, jul. 2013. ilus
Article in Es | LILACS | ID: lil-695768
Responsible library: CL1.1
ABSTRACT

Background:

Implementation of health programs to reduce cardiovascular risk, are needed for secondary prevention of cardiovascular diseases.

Aim:

To evalúate achievements of secondary prevention goals, pharmacologic prescription and major cardiovascular events in patients with coronary artery disease. Material and

Methods:

Patients who had a first event of acute coronary syndrome, angioplasty or revascularization surgery, between January 2008 and June 2010, were contacted for a clinical and laboratory evaluation between June and October 2011.

Results:

Seven hundred and two medical records were reviewed and 245 eligible patients were identified. Ofthese, we assessed 202 patients aged 64 ± 10 years (70% males). Sixty seven percent had two ormore cardiovascular riskfactors. A goal ofHDL cholesterol level over 40 mg/dL was achieved in 91 % of patients, smoking cessation in 84% and a total cholesterol < 200 mg/dL in 66%. A blood pressure below 130/85 mm Hgwas achieved in 30% of patients, a normal BMI in 19% and LDL cholesterol levels below 70 mg/dL in 18%. At the moment of assessment, 87%> were using aspirin, 78%> statins, 74% angiotensin converting enzyme inhibitors or angiotensin II receptor antagonists and 66%o were using β - blockers. Twenty two percent of patients had a major cardiovascular event during the follow up, which lasted 28 ± 8 months.

Conclusions:

A low percentage of cardiovascular goals achievement was observed in this sample of patients, with a high prevalence of overweight and obesity. A high percentage quit smoking after their first cardiovascular event. Despite the high percentage of drug prescription, hypertension and dyslipidemia were not fully controlled.
Subject(s)
Key words

Full text: 1 Index: LILACS Main subject: Drug Prescriptions / Cardiovascular Diseases Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Aged / Female / Humans / Male Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2013 Type: Article

Full text: 1 Index: LILACS Main subject: Drug Prescriptions / Cardiovascular Diseases Type of study: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Aged / Female / Humans / Male Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2013 Type: Article